Vennema H. et al., Early death after feline infectious peritonitis computer virus challenge due to recombinant vaccinia computer virus immunization. Coronavirus 2 (SARS-CoV-2) and shown to be closely related to SARS-CoV and several SARS-like bat CoVs(1). Despite the urgent need, there are currently no approved vaccines or therapeutics available for the prevention or treatment of COVID-19. Furthermore, the recurrent zoonotic spillover of CoVs into humans, along with the broad diversity of SARS-like CoV strains circulating in animal reservoirs, suggests that novel pathogenic CoVs are likely to emerge in the future and underscores the need for broadly active countermeasures. Tafenoquine Succinate CoV access into host cells is usually mediated by the viral S glycoprotein, which forms trimeric spikes around the viral surface(2). Each monomer in the trimeric S assembly is usually a heterodimer of S1 and S2 subunits. The S1 subunit is composed of four domains: an N-terminal domain name (NTD), a C-terminal domain name (CTD), and subdomains I and II(3C5). The CTD of both SARS-CoV and SARS-CoV-2 functions as the receptor-binding domain name (RBD) for the shared entry receptor, human angiotensin transforming enzyme 2 (hACE2)(6C10). The S2 subunit contains the fusion peptide, heptad repeat 1 and 2, Tafenoquine Succinate and a transmembrane domain name, all of which are required for fusion of the viral and host cell membranes. The S glycoprotein of human CoVs (HCoVs) is the main target for neutralizing antibodies (nAbs)(11). Given that SARS-CoV and SARS-CoV-2 share about 80% amino acid Tafenoquine Succinate identity in their S proteins, one important immunological question issues the immunogenicity of conserved surfaces on these antigens. Studies of convalescent sera and a limited quantity of monoclonal antibodies (mAbs) have revealed limited to no cross-neutralizing activity, demonstrating that conserved antigenic sites are rarely targeted by nAbs(5, 9, 12). However, the frequencies, specificities, and functional activities of cross-reactive antibodies induced by natural SARS-CoV and SARS-CoV-2 contamination remain poorly defined. In this study, we aimed to comprehensively profile the cross-reactive B cell response induced by Tafenoquine Succinate SARS-CoV contamination by cloning an extensive panel of SARS-CoV-2 S-reactive mAbs from your peripheral B cells of a convalescent donor (Donor 84) who survived the 2003 SARS outbreak. To isolate cross-reactive antibodies, we stained purified B cells with a panel of memory B cell (MBC) markers and a fluorescently labeled recombinant SARS-CoV-2 S protein. Flow cytometric analysis revealed that 0.14% of class-switched MBCs were SARS-CoV-2 S-reactive, which was about 3-fold over background staining observed with a SARS-CoV-na?ve donor BST1 sample (Fig. 1A). Notably, the frequency of antigen-specific MBCs was higher than expected, given the long interval between contamination and blood draw (17 years) and previous studies showing waning of SARS-CoV-specific MBCs to undetectable levels within 6 years(13). Cognate antibody heavy- and light-chain pairs were rescued from 315 individual SARS-CoV-2-reactive B cells by single-cell RT-PCR and subsequently cloned and expressed as full-length IgGs in an designed strain of Saccharomyces cerevisiae(14). Of the 315 cloned antibodies, 200 bound to SARS-CoV-2 S in preliminary binding screens (Fig. 1B). Sequence analysis revealed that about half of the clones were members of expanded clonal lineages, whereas the other half were unique (Fig. 1C). This result is in stark contrast to numerous studies of other main viral infections reporting very limited clonal growth within virus-specific MBC repertoires(15C18). Moreover, about 30% of isolated antibodies displayed convergent VH1C69/VK2C30 germline gene pairing (Fig. 1C). As expected, almost all the antibodies were somatically mutated, with users of clonally expanded lineages showing significantly higher levels of somatic hypermutation (SHM) compared to unique clones (Fig. 1D). Finally, consistent with the respiratory nature of SARS-CoV contamination, index sorting analysis revealed that 33% of binding antibodies originated from IgA+ MBCs and the remaining 66% from IgG+ MBCs (Fig. 1E). We conclude that SARS-CoV contamination elicited a high frequency of long-lived, cross-reactive MBCs in Tafenoquine Succinate this donor. Open in a separate window Physique 1. Isolation of SARS-CoV-2 S-specific IgGs. (A) Frequency of SARS-CoV-2 S-reactive B cells in Donor 84 and a negative control SARS-CoV-na?ve donor. Fluorescence activated cell sorting (FACS) plots shown are gated on CD19+CD20+IgD?IgM? B cells. SARS-CoV-2 S was labeled with two different colors to reduce background.